Drug Shortages

ASCO Resources Related to Drug Shortages

The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below.

Shortages are so severe and prolonged that for the first time in years policymakers are exploring comprehensive solutions addressing the issue. Sign the Association for Clinical Oncology’s (ASCO) letter from America’s cancer doctors and providers and add your voice to the urgent call for action. Tell policymakers now is the time to fix drug shortages.

To further assist ASCO’s advocacy efforts on this issue, or to share comments, concerns, suggestions for best practices, etc. please contact ASCO


Answers to questions about oncology drug shortages published herein are provided by the American Society of Clinical Oncology, Inc. (“ASCO”) for voluntary, informational use by providers in the rapidly evolving drug shortage crisis. This information does not constitute medical or legal advice, is not intended for use in the diagnosis or treatment of individual conditions, does not endorse products or therapies, recommend or mandate any particular course of medical care, and is not a statement of the standard of care. New evidence may emerge between the time information is developed and when it is published or read. The information is not comprehensive or continually updated. This information is not intended to substitute for the independent professional judgment of the treating provider in the context of treating the individual patient. ASCO provides this information on an “as is” basis, and makes no warranty, express or implied, regarding the information. ASCO specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Use of the information is subject to the complete ASCO website Terms of Use.

Random Quote

"I value the broad exposure ASCO affords my specialty throughout the oncology world. All of us have the opportunity to learn about the latest advances in our field and to broadly share our own research."
Clifford Hudis, MD, FASCO